美国退伍军人肢端黑色素瘤危险因素识别
该巢式病例对照研究(2000-2024)在退伍军人健康系统中,将1292例肢端黑色素瘤(AM)与无黑色素瘤对照及非肢端皮肤黑色素瘤(CM)对照匹配,分析多种暴露因素。结果提示橙剂暴露与AM风险升高相关,当前吸烟与风险降低相关,既往史与AM风险存在关联。
要点
- 橙剂暴露与AM风险升高相关(vs CM AOR 1.31;vs 无黑色素瘤对照 AOR 1.27)。
- 当前吸烟与AM风险降低相关(vs CM AOR 0.65;vs 无黑色素瘤对照 AOR 0.50)。
- 既往角化细胞癌和光化性角化病与无黑色素瘤对照相比风险升高,但与非肢端CM相比风险降低。
核心结论
- 多种因素与美国退伍军人肢端黑色素瘤风险相关。
- 橙剂暴露与肢端黑色素瘤风险升高相关。
- 当前吸烟与肢端黑色素瘤风险降低相关。
- 需要继续将肢端黑色素瘤作为独立于非肢端皮肤黑色素瘤的疾病进行研究。
研究设计与样本
- 巢式病例对照研究,2000-2024年,退伍军人事务医疗系统。
- 1292例肢端黑色素瘤患者匹配5168例无黑色素瘤对照。
- 1286例肢端黑色素瘤患者匹配5144例非肢端皮肤黑色素瘤对照。
- 匹配因素为诊断年份和门诊就诊频率。
主要发现
- 橙剂暴露与AM风险升高相关:vs CM AOR 1.31(95%CI 1.06-1.62);vs 无黑色素瘤对照 AOR 1.27(95%CI 1.04-1.56)。
- 当前吸烟与AM风险降低相关:vs CM AOR 0.65(95%CI 0.52-0.81);vs 无黑色素瘤对照 AOR 0.50(95%CI 0.40-0.62)。
- 既往角化细胞癌和光化性角化病与无黑色素瘤对照相比AM风险升高,但与非肢端CM相比风险降低。
- 既往痣与无黑色素瘤对照相比AM风险升高。
临床怎么用
- 在退伍军人中评估肢端黑色素瘤风险时应考虑橙剂暴露史。
- 当前吸烟与肢端黑色素瘤风险降低的关联需谨慎解读,不应作为吸烟保护性证据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Acral melanoma (AM), localized to the palms, soles, and nail units, is a unique melanoma subtype less associated with UV radiation. Few studies have evaluated AM risk factors in a population of US veterans. OBJECTIVE: To identify AM risk factors in US veterans. DESIGN, SETTING, AND PARTICIPANTS: Nested case-control study (2000-2024) in the Veterans Affairs (VA) health care system. Individuals with AM were identified using the VA Cancer Registry and a validated natural language processing pipeline applied to pathology reports. Each AM case was matched to 4 nonacral cutaneous melanoma (CM) controls and 4 controls with no melanoma diagnoses at any time by diagnosis year and outpatient visit frequency. Controls with acral, mucosal, or ocular melanoma diagnoses at any time were excluded. Participants were veterans with histologically confirmed AM, nonacral CM controls, and controls with no melanoma diagnoses at any time. EXPOSURE: Age, sex, race and ethnicity, rurality, region, military branch, comorbidities (National Cancer Institute Comorbidity Index), smoking status, unhealthy alcohol use as measured by the Alcohol Use Disorders Identification Test-Consumption, body mass index, Agent Orange exposure (AOE), prior photosensitizing medications, nevi, keratinocyte carcinoma (KC), actinic keratosis (AK), and number of dermatology visits in the 2 years before diagnosis. MAIN OUTCOMES AND MEASURES: Adjusted odds ratios (AORs) comparing AM with controls using conditional logistic regression. Secondary outcomes included analyses limited to Vietnam Era veterans and AM localized to palmoplantar and subungual sites. RESULTS: In total, 1292 individuals with AM (median age, 70.13 [IQR, 61.87-78.66] years; 1215 [94.0%] male) were matched to 5168 controls without melanoma (median age, 73.97 [IQR, 65.53-82.08] years; 5044 [97.6%] male), and 1286 individuals with AM (median age, 70.13 [IQR, 61.97-78.67] years; 1210 [94.1%] male) were matched to 5144 CM controls (median age, 74.58 [IQR, 66.86-82.05] years; 5068 [98.5%] male); 6 individuals with AM were excluded from AM vs CM analyses due to lack of matches. AOE was significantly associated with higher odds of AM vs CM (AOR, 1.31; 95% CI, 1.06-1.62) and vs controls without melanoma (AOR, 1.27; 95% CI, 1.04-1.56). Current smoking was associated with lower odds of AM (vs CM: AOR, 0.65; 95% CI, 0.52-0.81; vs controls without melanoma: AOR, 0.50; 95% CI, 0.40-0.62). Prior KC and AK were associated with higher odds vs controls without melanoma but lower odds vs CM. Prior nevus was associated with higher odds of AM vs controls without melanoma. CONCLUSIONS AND RELEVANCE: Results of this study suggest that several factors were associated with AM in veterans and a need for continued investigation of AM as a distinct entity from CM and may inform future evaluations of the associations between AOE and AM in veteran populations.
引用
- Hwang JC, Huhmann LB, Cho K, et al. Identification of Risk Factors for Acral Melanoma in US Veterans. JAMA Dermatol. 2026. PMID: 41637103. doi:10.1001/jamadermatol.2025.5827
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。